Literature DB >> 25931833

D1 versus D2 dissection in gastric carcinoma: Evaluation of postoperative mortality and complications.

Veli Vural1, Barış Saylam1, Bülent Çomçalı1, Arife Polat Düzgün1, Mehmet Vasfi Özer1, Faruk Coşkun1.   

Abstract

OBJECTIVE: Surgery is the only curative treatment for patients with gastric cancer. However, the extent of lymph node dissection is still debated. The aim of the study was to evaluate complications, postoperative length of hospital stay and postoperative mortality after D1 or D2 lymph node dissection for gastric cancer in a non-specialized hospital.
MATERIAL AND METHODS: All patients who underwent surgery for pathologically confirmed gastric cancer at our 3rd General Surgery Department, Ankara Numune Training Hospital between January 1999 and 2007 were retrospectively reviewed. A consecutive series of 71 gastric cancer patients was identified. D1 resection (level 1 lymphadenectomy) was compared with D2 resection (levels 1 and 2 lymphadenectomy).
RESULTS: The D2 group had higher postoperative mortality (16% vs. 8%; p<0.005) and morbidity (54% vs. 34%; p<0.005), and their postoperative length of stay was longer. Splenectomy did not have an effect on postoperative morbidity and mortality in either the D1 or the D2 group.
CONCLUSION: The D2 procedure was associated with significantly higher postoperative mortality, morbidity, and postoperative length of hospital stay.

Entities:  

Keywords:  Mortality; gastric cancer; morbidity; surgery

Year:  2013        PMID: 25931833      PMCID: PMC4379771          DOI: 10.5152/UCD.2013.01

Source DB:  PubMed          Journal:  Ulus Cerrahi Derg        ISSN: 1300-0705


  21 in total

1.  Lymph node metastases of gastric cancer. General pattern in 1931 patients.

Authors:  K Maruyama; P Gunvén; K Okabayashi; M Sasako; T Kinoshita
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

2.  Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer.

Authors:  Y Kodera; Y Yamamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  J Am Coll Surg       Date:  1997-07       Impact factor: 6.113

3.  [Clinical values of extended lymph node dissection for gastric cancer:a meta-analysis for D1 versus D2 gastrectomy].

Authors:  Xue-fei Wang; Yi-hong Sun; De-ji Liang; Cong Wang; Yong Fang; Tian-shu Liu; Xin-yu Qin
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2007-09

4.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma.

Authors:  D M Dent; M V Madden; S K Price
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

5.  Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.

Authors:  Franco Roviello; Daniele Marrelli; Paolo Morgagni; Giovanni de Manzoni; Alberto Di Leo; Carla Vindigni; Luca Saragoni; Anna Tomezzoli; Hayato Kurihara
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

6.  Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group.

Authors:  J R Siewert; K Böttcher; J D Roder; R Busch; P Hermanek; H J Meyer
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

7.  Cancer of the stomach. A patient care study by the American College of Surgeons.

Authors:  H J Wanebo; B J Kennedy; J Chmiel; G Steele; D Winchester; R Osteen
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

8.  Gastric cancer surgery and its hazards: post operative infection is the most important complication.

Authors:  B K Sah; Z G Zhu; M M Chen; M Yan; Hao Ran Yin; Lin Yan Zhen
Journal:  Hepatogastroenterology       Date:  2008 Nov-Dec

9.  [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].

Authors:  A Necula; L Vlad; C Iancu; D Munteanu; C Puia; O Bălă; N AlHajaar; F Pop; H Radu; G Osian; F Graur; Luminiţa Furcea; M Stanca; G Molnar; L Mocanu
Journal:  Chirurgia (Bucur)       Date:  2008 Sep-Oct

10.  [Prognostic and therapeutic value of D2 lymphadenectomy in the treatment of gastric cancer: experience of an Italian team].

Authors:  Giancarlo Candela; Varriale Sergio; Lorenzo Di Libero; Fiorenza Manetta; Marco Giordano; Michele Lanza; Giovanni Scetta; Alessandra Pizza; Valerio Sciascia; Salvatore Napolitano; Francesco D'Aniello; Vincenzo Casaburi; Daniela Esposito; Gerardo Sarno; Luigi Santini
Journal:  Chir Ital       Date:  2008 Sep-Oct
View more
  5 in total

Review 1.  Do all the European surgeons perform the same D2? The need of D2 audit in Europe.

Authors:  Maria Bencivenga; Giuseppe Verlato; Valentina Mengardo; Jacopo Weindelmayer; William H Allum
Journal:  Updates Surg       Date:  2018-06-04

2.  Comparison of open and laparoscopic gastrectomy for gastric cancer: a low volume center experience.

Authors:  Adem Yüksel; Murat Coşkun; Hamdi Taner Turgut; Fatih Sümer
Journal:  Turk J Surg       Date:  2021-03-22

Review 3.  Bursectomy at radical gastrectomy.

Authors:  Cuneyt Kayaalp
Journal:  World J Gastrointest Surg       Date:  2015-10-27

4.  Risk factors and laboratory markers used to predict leakage in esophagojejunal anastomotic leakage after total gastrectomy.

Authors:  Durmuş Ali Çetin; Ebubekir Gündeş; Hüseyin Çiyiltepe; Ulaş Aday; Orhan Uzun; Kamuran Cumhur Değer; Mustafa Duman
Journal:  Turk J Surg       Date:  2018-11-20

5.  Significance of Gastric Wall Thickening Detected in Abdominal CT Scan to Predict Gastric Malignancy.

Authors:  A Akbas; H Bakir; M F Dasiran; H Dagmura; Z Ozmen; N Yildiz Celtek; E Daldal; O Demir; A Kefeli; I Okan
Journal:  J Oncol       Date:  2019-11-20       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.